Lipocine Announces Financial and Operational Results for the First Quarter of 2014
May 13, 2014 08:30 ET
|
Lipocine Inc.
SALT LAKE CITY, May 13, 2014 (GLOBE NEWSWIRE) -- Lipocine Inc. (Nasdaq:LPCN), a specialty pharmaceutical company, announced today announced financial results for the quarter ended March 31, 2014, as...
Lipocine Announces Completion of Enrollment in its SOAR Phase 3 Study for Oral Testosterone Replacement Therapy
April 29, 2014 08:00 ET
|
Lipocine Inc.
- Top-line Efficacy Data Expected in 3Q14
- NDA filing expected in 2H15
SALT LAKE CITY, April 29, 2014 (GLOBE NEWSWIRE) -- Lipocine Inc. (Nasdaq:LPCN), a specialty pharmaceutical company, today...
Lipocine to Begin Trading on the NASDAQ Capital Market
March 18, 2014 08:30 ET
|
Lipocine Inc.
SALT LAKE CITY, March 18, 2014 (GLOBE NEWSWIRE) -- Lipocine Inc. (OTCQB:LPCN), a specialty pharmaceutical company, today announced that it has received confirmation that its application to list the...
Lipocine to Present at the 26th Annual ROTH Conference
March 05, 2014 08:30 ET
|
Lipocine Inc.
SALT LAKE CITY, March 5, 2014 (GLOBE NEWSWIRE) -- Lipocine Inc. (OTCQB:LPCN), a specialty pharmaceutical company, today announced Mahesh Patel, President and CEO, and Morgan Brown, Executive Vice...
Lipocine Announces First Patient Dosed in Phase 3 Study for Oral Testosterone Replacement Therapy
February 10, 2014 08:30 ET
|
Lipocine Inc.
SALT LAKE CITY, Feb. 10, 2014 (GLOBE NEWSWIRE) -- Lipocine Inc. (OTCQB:LPCN), a specialty pharmaceutical company, today announced that the first patient has been dosed in its Study of Oral Androgen...
Lipocine to Present at the 2014 Leerink Global Healthcare Conference
February 04, 2014 08:30 ET
|
Lipocine Inc.
SALT LAKE CITY, Feb. 4, 2014 (GLOBE NEWSWIRE) -- Lipocine Inc. (OTCQB:LPCN), a specialty pharmaceutical company, today announced Mahesh Patel, President and CEO, and Morgan Brown, Executive Vice...
Lipocine Announces New Appointments to Its Board of Directors
January 07, 2014 16:00 ET
|
Lipocine Inc.
SALT LAKE CITY, Jan. 7, 2014 (GLOBE NEWSWIRE) -- Lipocine Inc. (OTCQB:LPCN) (OTCBB:LPCN), a specialty pharmaceutical company, today announced changes to the Company's Board of Directors, including the...
Lipocine Chairman Receives Honorary Doctor of Science Degree From the University of Michigan
December 13, 2013 16:30 ET
|
Lipocine Inc.
SALT LAKE CITY, Dec. 13, 2013 (GLOBE NEWSWIRE) -- Lipocine Inc. (OTCQB:LPCN) (OTCBB:LPCN), a specialty pharmaceutical company, today announced that Dr. William I. Higuchi will receive an honorary...
Lipocine Inc. Announces Exercise and Closing of Over-Allotment Option
December 06, 2013 16:00 ET
|
Lipocine Inc.
SALT LAKE CITY, Dec. 6, 2013 (GLOBE NEWSWIRE) -- Lipocine Inc. (OTCQB:LPCN), a specialty pharmaceutical company, today announced that the underwriters of its previously announced public offering have...
Lipocine Inc. Announces Pricing of Public Offering of Common Stock
November 27, 2013 08:30 ET
|
Lipocine Inc.
SALT LAKE CITY, Nov. 27, 2013 (GLOBE NEWSWIRE) -- Lipocine Inc. (OTCQB:LPCN) (OTCBB:LPCN), a specialty pharmaceutical company, today announced the pricing of an underwritten public offering of...